Should You Buy Palantir Stock Before Feb. 2?

Palantir is set to report Q4 and FY2025 results after the close on Feb. 2 with prior guidance of Q4 revenue of $1.3 billion and adjusted operating income of $695–$699 million, and full-year revenue around $4.4 billion with adjusted operating income of $2.2 billion and adjusted free cash flow of $2.0 billion. Meeting guidance would imply ~51% revenue growth year-over-year, operating income roughly doubling and FCF up ~60%; the company has a track record of beating expectations and driving strong post-earnings rallies, but the shares carry a historically high P/S of ~111 and have seen recent selling pressure, suggesting upside tied closely to execution against lofty forecasts.

Analysis

Market structure: A beat that validates Palantir’s $4.4B 2025 revenue guide (≈+51% YoY) will reinforce enterprise AI software as a high-margin winner vs. legacy IT spend, benefiting PLTR, cloud integrators, and data-platform partners while pressuring lower-margin analytics vendors. The market already prices extreme growth (P/S ≈111); that concentration creates fragility — upside likely quick and binary around Feb 2 earnings, downside amplified if guidance misses by >5%-10%.

Risk assessment: Immediate (days) risk is elevated IV and 20–40% intraday swings around earnings; short-term (weeks) risk centers on guidance cadence and customer renewal data; long-term (quarters/years) risks include government contract churn, regulatory limits on data use, or AI commoditization compressing pricing power. Tail scenarios: a major U.S./UK contract cancellation or adverse regulation could wipe out 20–40% of forward revenue and trigger >50% share collapse.

Trade implications: For directional exposure prefer small, hedged stakes — keep position sizes modest (2–3% NAV) and use protective options or collars; consider 3–6 month call spreads to cap cost if bullish, or buy 30–45 day puts if short-term hedging. Relative-value: go long PLTR and short a proxy for hardware-dominated AI exposure (e.g., NVDA) sized 1:0.25 to express software-outperformance while limiting market-beta.

Contrarian angles: Consensus prizes beats; it underweights valuation risk — a 5% revenue miss could justify >30% downside given P/S 111. Historical parallels (rapid post-earnings spikes then mean reversion) suggest trades should target event-driven gamma, not unhedged buy-and-hold; unintended consequence of a strong print is increased short-term selling by momentum sellers taking profits, creating mean-reversion opportunities within 5–30 trading days.

Key Decisions for Investors

• Establish a 2–3% NAV long position in PLTR ahead of Feb 2 earnings, funded gradually (50% immediately, 50% on a ≤5% pullback); place a hard stop at -15% absolute or implement a collar using a 3-month 10% OTM put and finance with a 3-month 25% OTM call.
• If bullish on post-earnings follow-through, buy a 3-month call spread (buy 30-delta call, sell 10-delta call) sized to 1% NAV to limit cost while capturing upside if guidance is reiterated; cap loss to premium paid.
• If neutral-to-bearish, buy 30–45 day PLTR puts 5–10% OTM or sell a 7–14 day iron condor after earnings only if IV collapses; target net premium capture >3% of NAV with defined risk and close within 10 trading days post-earnings.
• Execute a pair trade: long PLTR (1% NAV) vs short NVDA (0.25% NAV) for 3–6 months to express software/analytics outperformance versus hardware, and rebalance if relative move >20% or macro rate volatility spikes.
• Monitor within 30 days: (1) management commentary on contract concentration (top-5 customers % of revenue), (2) FY26 ARR-like metrics and gross retention; if top-5 share >40% or retention <85%, reduce PLTR exposure by 50%.